CVE-2022-26041: Generex Rccmd

Medium severity, CVSS 6.5. EPSS: 1.5% chance of exploitation in the next 30 days.

Directory traversal vulnerability in RCCMD 4.26 and earlier allows a remote authenticated attacker with an administrative privilege to read or alter an arbitrary file on the server via unspecified vectors.

Affected products

• Generex Rccmd: up to and including 4.26

Published 2022-06-13. Last modified 2026-06-17.